Toxin-induced movement disorders.
Toxins can be cited as a cause of several movement disorders, but this association is rare and the resultant syndromes usually include additional signs that are not typical for the idiopathic movement disorders. Most instances of confirmed toxin-induced movement disorders show lesions on CT and MRI scans of cortical or subcortical structures. A common underlying element in these toxin-induced syndromes is the development of lesions primarily in the pallidum and striatum. Because many toxins result in lesions affecting these structures, a selective vulnerability to hypoxic or metabolic insults has long been postulated. The susceptibility of these structures may relate to a number of factors, including the pattern of oxidative metabolism, heavy metal concentration, vascular perfusion, and neuronal innervation. Finally, in addition to causing disability, certain neurotoxins have led to a better understanding of human disease through the development of research models. As an example, the MPTP model has not only provided an animal model to study therapeutic strategies in PD but has also contributed important insights into the mechanism of neuronal degeneration.
Pappert
Eric J
EJ
Division of Neurology, Department of Medicine, University of Texas, Health Science Center, 2379 NE Loop 410, Suite 12, San Antonio, TX 78217, USA. pappert@uthscsa.edu
D000818:Animals; D001921:Brain / Q000187:drug effects; D006801:Humans; D009069:Movement Disorders / Q000209:etiology / Q000503:physiopathology; D014118:Toxins, Biological / Q000009:adverse effects*
D014118:Toxins, Biological